Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

HitGen receives Gates grant
October 2018
SHARING OPTIONS:

CHENGDU, China—HitGen Ltd. was recently awarded a three-year grant from the Bill & Melinda Gates Foundation to apply its DNA-encoded library technology toward the discovery of new small-molecule therapies for treating malaria and tuberculosis. Experts and partners at the Foundation will offer materials, expertise and resources for this effort.
 
“We are excited to collaborate with our colleagues at the Bill & Melinda Gates Foundation as a strategic partner for these discovery efforts: we acknowledge their philanthropic mission, and are indeed privileged to be able to contribute to their remarkable vision and effort,” said Dr. Jin Li, HitGen’s founder, chairman and CEO. “HitGen continues to grow as a world-class drug discovery organization. In addition to our collaborations with industry partners, we are keenly focused on engaging with world-leading philanthropic and academic institutions to provide new solutions for patients with unmet medical needs.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.